BioSeek to Continue in ToxCast Program | GenomeWeb

NEW YORK (GenomeWeb News) – BioSeek said today that it has expanded an agreement with the Environmental Protection Agency, under which EPA will use the firm's BioMap in the second phase of its ToxCast program.

Under the agreement, EPA will use the BioMap, which employs cell-based disease models to generate activity profiles of potential drugs, to study the biological effects of certain chemicals and help the agency select new candidates. BioSeek also will use its technology to assess the impact of these chemicals on the environment and on human health.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.